Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Dec
16
2016
21st Century Cures Act Grants Additional Grandfathered Status to Some Off-Campus Hospital Outpatient Departments Faegre Drinker
Dec
15
2016
Recent Federal Developments, December 2016: EPA Proposes To Add Nonylphenol Ethoxylates To Section 313; EPA Proposes Prohibiting Use Of TCE; EPA Issues Final Rule Updating CAA Refrigerant Management Requirements Bergeson & Campbell, P.C.
Dec
15
2016
FDA's Ingredient Listing Deadline Rapidly Approaching for Manufacturers of E-Vapor, E-Liquid and Other Deemed Tobacco Products Keller and Heckman LLP
Dec
15
2016
FDA Increases Transparency of Adverse Event Data for Cosmetics and Foods Mintz
Dec
15
2016
21st Century Cures Act’s Effect on Pharmaceutical and Biotechnology Industries Morgan, Lewis & Bockius LLP
Dec
15
2016
FDA Issues Final Guidance for Voluntary Qualified Importer Program Under FSMA Keller and Heckman LLP
Dec
15
2016
21st Century Cures: Examining Provisions for Streamlining FDA Regulations for Clinical Research in Title III McDermott Will & Emery
Dec
15
2016
FDA Finalizes FSMA Third-Party Certification User Fee Program Keller and Heckman LLP
Dec
14
2016
Working Through The Haze: What Legal Marijuana Means For Nevada Employers Holland & Hart LLP
Dec
14
2016
Robotic Movement Tests May Predict Post-Concussion Syndrome [VIDEO] Stark & Stark
Dec
14
2016
FDA Issues Draft Guidance on “Fruit Juice and Vegetable Juice as Color Additives in Food” Keller and Heckman LLP
Dec
13
2016
Major FDA Reform Bill Becomes Law: Medical Device Overview Barnes & Thornburg LLP
Dec
13
2016
New EU Guidance Documents on Authorization of Novel and Traditional Foods Now Available Keller and Heckman LLP
Dec
13
2016
Solicitor General Sides With Sandoz On Interpretation Of Biosimilar Statute Foley & Lardner LLP
Dec
12
2016
Scientific Evaluator Discusses Regulation of Food-Contact Materials in Canada Keller and Heckman LLP
Dec
12
2016
Florida: No Telemedicine Exams for Medical Marijuana Foley & Lardner LLP
Dec
12
2016
Fishy Business: National Oceanic and Atmospheric Administration Finalizes Seafood Traceability Rule Keller and Heckman LLP
Dec
12
2016
Improper Marketing of Abilify, DOJ and Internet Gambling: State Attorneys General December 12 Update Squire Patton Boggs (US) LLP
Dec
12
2016
Effective Dec 1, Pharmacies, Prescribers, and Wholesalers Must Report Gabapentin to Ohio Automated Rx Reporting System Dinsmore & Shohl LLP
Dec
12
2016
China Food and Drug Administration Releases Draft Classification Catalogue of Medical Devices Covington & Burling LLP
Dec
9
2016
The Week Ahead in the European Parliament – December 9, 2016 Covington & Burling LLP
Dec
9
2016
FDA Issues Draft Guidance on FCN Submissions for Substances Intended to Contact Infant Food Keller and Heckman LLP
Dec
9
2016
Senate Passes 21st Century Cures Act, but Can It Cure an Ailing FDA? Mintz
Dec
9
2016
USDA Scientists Develop New Method for Detecting Acrylamide in Potatoes Keller and Heckman LLP
Dec
8
2016
What a Trump Administration Could Mean for the 340B Drug Program K&L Gates
Dec
8
2016
Global Enforcement of the Nagoya Protocol in Life Sciences Industries Covington & Burling LLP
Dec
8
2016
In the Wake of the Election, What’s Next for State Drug Pricing Initiatives? Mintz
Dec
8
2016
Cannabis Conundrum: Hurdles to Trademark Protection in a “Growing” Industry Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins